In spite of the fact that the problem has been studied over many decades, the factors that adjust the cerebral blood flow (CBF) to functional and metabolic demands have not yet been defined. Re cent results indicate that some of these missing coupling factors may be provided by products of the fatty acid cyclo-oxygenase, i. e. , by prostaglandins and related substances. The evidence comes from Abbreviations used: Cao2, oxygen content; A VD02, ar teriovenous oxygen difference.
109studies in which the cyclo-oxygenase was inhibited by indomethacin, a potent inhibitor of the enzyme in brain and other tissues (see Flower, 1974; Wolfe et aI. , 1976; Abdel-Halim et aI. , 1978). The original report describing an effect of in domethacin on CBF was published by Pickard and MacKenzie (1973), who administered the drug by intravenous (10 mg kg-I) or intracarotid (0.04-0.2 mg kg-I min-I) routes in phencyclidine-N20 anesthetized baboons, measuring CBF with a 133Xe clearance technique. The authors found that the drug reduced control CBF by an average of 38% and that it markedly attenuated the CBF response to